tiprankstipranks

Steven Shallcross Insider Profile

4 Followers
Steven Shallcross, CEO and CFO, Director at Synthetic Biologics, holds 50.00K shares in Synthetic Biologics (Ticker: SYN), holds ― shares in Elys Game Technology (Ticker: ELYS), holds 0.00 shares in Vanda (Ticker: VNDA). Most recently, Steven Shallcross Bought ― shares of Synthetic Biologics on Aug 26, 2019 for an estimated value of 20.50K.
tipranks
Steven Shallcross

Steven Shallcross
Synthetic Biologics (SYN)
CEO and CFO, Director

Not Ranked
Steven Shallcross has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$19K
100.00%
0.00%
0.00%
0.00%
A breakdown of Steven Shallcross's holdings

Insider Roles

Synthetic Biologics
(SYN)
CEO and CFO, Director
Elys Game Technology
(ELYS)
Director
Vanda
(VNDA)
Sr. VP, CFO, Treasurer
Nuo Therapeutics
(AURX)
SEE REMARKS
Roles that Steven Shallcross holds in companies

Most Profitable Insider Trade

Stock:
Synthetic Biologics
(SYN)
Rating:Informative Buy
Date:Aug 26, 2019 - Aug 26, 2020
Return:+38.60%
The most profitable trade made by Steven Shallcross

Steven Shallcross's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Synthetic Biologics
Aug 26, 2019
CEO and CFO, Director
Informative Buy
20.50K
$18.70K
Elys Game Technology
Director
Vanda
Sr. VP, CFO, Treasurer
$0.00
Nuo Therapeutics
Aug 27, 2014
SEE REMARKS
Informative Buy
10.45K
List of latest transactions for each holding click on a transaction to see Steven Shallcross's performance on stock

Steven Shallcross insider profile FAQ

What is the percentage of profitable transactions made by Steven Shallcross?
The percentage of profitable transactions made by Steven Shallcross is ―.
    What is the average return per transaction made by Steven Shallcross?
    The average return per transaction made by Steven Shallcross is ―.
      What stocks does Steven Shallcross hold?
      Steven Shallcross holds: SYN, ELYS, VNDA, AURX stocks.
        What was Steven Shallcross’s latest transaction?
        Steven Shallcross latest transaction was an Informative Buy of $20.50K.
          What was Steven Shallcross's most profitable transaction?
          Steven Shallcross’s most profitable transaction was an Informative Buy of SYN stock on August 26, 2019. The return on the trade was 38.60%.
            What is Steven Shallcross's role in Synthetic Biologics?
            Steven Shallcross's role in Synthetic Biologics is CEO and CFO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.